These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21691055)

  • 41. Growth and hormonal profile from birth to adolescence of a girl with aromatase deficiency.
    Verma N; Jain V; Birla S; Jain R; Sharma A
    J Pediatr Endocrinol Metab; 2012; 25(11-12):1185-90. PubMed ID: 23329769
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
    Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term testolactone therapy for precocious puberty in girls with the McCune-Albright syndrome.
    Feuillan PP; Jones J; Cutler GB
    J Clin Endocrinol Metab; 1993 Sep; 77(3):647-51. PubMed ID: 8370686
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Aromatase inhibitors: can these agents improve skeletal growth?].
    Audí Parera L
    Endocrinol Nutr; 2009 May; 56(5):215-7. PubMed ID: 19627741
    [No Abstract]   [Full Text] [Related]  

  • 45. Development of the frontal sinus in relation to somatic and skeletal maturity. A cephalometric roentgenographic study at puberty.
    Ruf S; Pancherz H
    Eur J Orthod; 1996 Oct; 18(5):491-7. PubMed ID: 8942099
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stature and skeletal maturation of two cohorts of Australian children and young adults over the past two decades.
    Ranjitkar S; Lin NH; Macdonald R; Taylor JA; Townsend GC
    Aust Orthod J; 2006 May; 22(1):47-58. PubMed ID: 16792245
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of the effectiveness of treatment on adult height prognosis in disorders with advanced and retarded bone age. Height and height velocity related to chronological or to bone age.
    Bossi E; Joss EE; Zurbrügg RP
    Acta Paediatr Scand; 1973 Jul; 62(4):401-4. PubMed ID: 4354104
    [No Abstract]   [Full Text] [Related]  

  • 48. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.
    Boepple PA; Mansfield MJ; Wierman ME; Rudlin CR; Bode HH; Crigler JF; Crawford JD; Crowley WF
    Endocr Rev; 1986 Feb; 7(1):24-33. PubMed ID: 2937629
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of treatment on growth in congenital adrenal hyperplasia.
    Ercan O; Hatemi S; Kutlu E; Turan N
    Indian J Pediatr; 2000 Nov; 67(11):783-9. PubMed ID: 11216375
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Puberty and adult height in congenital virilizing adrenal hyperplasia (author's transl)].
    Himon F; Job JC; Pierson M; Canlorbe P
    Ann Pediatr (Paris); 1981 Mar; 28(3):187-92. PubMed ID: 7224567
    [No Abstract]   [Full Text] [Related]  

  • 51. Delayed closure of epiphyseal cartilages induced by the aromatase inhibitor anastrozole. Would it help short children grow up?
    Faglia G; Arosio M; Porretti S
    J Endocrinol Invest; 2000 Dec; 23(11):721-3. PubMed ID: 11194703
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adult height in precocious puberty after long-term treatment with deslorelin.
    Oerter KE; Manasco P; Barnes KM; Jones J; Hill S; Cutler GB
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1235-40. PubMed ID: 1955504
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Update on treatment strategies for optimization of final adult height in children with congenital adrenal hyperplasia.
    Javed A; Lteif A; Kumar S
    Pediatr Endocrinol Rev; 2012 Nov; 10(1):164-73. PubMed ID: 23469393
    [TBL] [Abstract][Full Text] [Related]  

  • 54. True precocious puberty complicating congenital adrenal hyperplasia: treatment with a luteinizing hormone-releasing hormone analog.
    Pescovitz OH; Comite F; Cassorla F; Dwyer AJ; Poth MA; Sperling MA; Hench K; McNemar A; Skerda M; Loriaux DL
    J Clin Endocrinol Metab; 1984 May; 58(5):857-61. PubMed ID: 6368580
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Growth and precocious puberty.
    Chaussain JL; Couprie C; Lacaille F; Simon D; Job JC
    Acta Paediatr Scand Suppl; 1988; 347():38-43. PubMed ID: 2978196
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Growth, bone maturation and height prediction after three years of therapy with the slow release GnRH-agonist Decapeptyl-Depot in children with central precocious puberty.
    Hümmelink R; Oostdijk W; Partsch CJ; Odink RJ; Drop SL; Sippell WG
    Horm Metab Res; 1992 Mar; 24(3):122-6. PubMed ID: 1533604
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Patterns of growth in congenital adrenal hyperplasia. Correlation between glucocorticoid therapy and stature].
    Igea JM; Lóridan L; Martul P; Ferrández A; Mayayo E; Rodríguez M; Oyarzábal M; Elcarte R; Luzuriaga C
    An Esp Pediatr; 1988 Oct; 29 Suppl 35():9-12. PubMed ID: 3272842
    [No Abstract]   [Full Text] [Related]  

  • 58. [Bone maturation during puberty. Apropos of 227 adolescents from Dakar].
    Michaut E; Niang I; Dan V
    Ann Radiol (Paris); 1972; 15(9):767-79. PubMed ID: 4342637
    [No Abstract]   [Full Text] [Related]  

  • 59. Use of aromatase inhibitors in children and adolescents: what's new?
    Diaz-Thomas A; Shulman D
    Curr Opin Pediatr; 2010 Aug; 22(4):501-7. PubMed ID: 20489637
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction of early puberty in a boy after treatment with oxandrolone?
    Doeker B; Müller-Michaels J; Andler W
    Horm Res; 1998; 50(1):46-8. PubMed ID: 9691214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.